Bionano Genomics, Inc.
BNGONasdaqCIK 1411690TechnologyFiscal year ends Dec 31
Reports and events: 184 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2717:13 ET | S-1 | Registration statement | 0001193125-26-434439 |
| 2026-09-1408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411690-26-000046 |
| 2026-08-1016:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001411690-26-000044 |
| 2026-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000043 |
| 2026-06-2408:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000040 |
| 2026-06-0516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001411690-26-000036 |
| 2026-05-2808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000033 |
| 2026-05-1416:29 ET | 8-K | 5.07 Shareholder vote results | 0001411690-26-000030 |
| 2026-05-1316:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001411690-26-000028 |
| 2026-05-1316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000027 |
| 2026-05-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001411690-26-000019 |
| 2026-04-0216:02 ET | DEF 14A | Proxy statementPeriod 2026-04-01 | 0001411690-26-000014 |
| 2026-03-2316:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001411690-26-000007 |
| 2026-03-2316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-26-000006 |
| 2026-01-1208:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-000904 |
| 2025-11-1316:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001411690-25-000093 |
| 2025-11-1316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000092 |
| 2025-09-1818:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035286 |
| 2025-09-1111:26 ET | S-1 | Registration statement | 0001140361-25-034651 |
| 2025-08-1416:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001411690-25-000083 |
| 2025-08-1416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000082 |
| 2025-06-1817:15 ET | 8-K/A | 5.07 Shareholder vote results | 0001411690-25-000077 |
| 2025-06-1316:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001411690-25-000073 |
| 2025-05-1416:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001411690-25-000046 |
| 2025-05-1416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000045 |
| 2025-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001140361-25-016025 |
| 2025-03-3116:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001411690-25-000037 |
| 2025-03-3116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000036 |
| 2025-02-2116:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-005427 |
| 2025-02-1017:16 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-25-003762 |
| 2025-01-2716:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411690-25-000008 |
| 2025-01-1616:36 ET | 8-K | 5.07 Shareholder vote results | 0001411690-25-000005 |
| 2025-01-1316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-25-000003 |
| 2025-01-0607:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000296 |
| 2025-01-0308:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000132 |
| 2024-12-0517:00 ET | DEF 14A | Proxy statementPeriod 2025-01-15 | 0001140361-24-048499 |
| 2024-12-0216:54 ET | 8-K | 5.07 Shareholder vote results | 0001411690-24-000066 |
| 2024-11-1416:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001411690-24-000063 |
| 2024-11-1316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-24-000060 |
| 2024-10-3108:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-044715 |
| 2024-10-1008:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-043244 |
| 2024-09-0908:00 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040508 |
| 2024-08-2116:59 ET | DEF 14A | Proxy statementPeriod 2024-10-02 | 0001140361-24-038087 |
| 2024-08-0716:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001411690-24-000049 |
| 2024-08-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001411690-24-000046 |
| 2024-07-1816:17 ET | 8-K | 3.01 Delisting notice | 0001411690-24-000044 |
| 2024-07-0806:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-032559 |
| 2024-06-2116:01 ET | 8-K | 5.07 Shareholder vote results | 0001411690-24-000040 |
| 2024-05-2808:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-027553 |
| 2024-05-0816:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001411690-24-000021 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:14 ET. Listed shows no prices and gives no investment advice.